A bone hemostatic repair material capable of being arbitrarily shaped and a preparation method thereof
By using bone hemostatic repair materials with bioactive glass and fat-soluble excipients, the problems of poor biocompatibility and uncontrollable degradation of bone hemostatic repair materials in the prior art are solved, and the effects of effective hemostatic and bone defect filling are achieved. Good biocompatibility and degradability, suitable for the repair of bone defects.
Patent Information
- Application Number
- CN202410416971.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-08
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-04-08
AI Technical Summary
The existing bone hemostasis repair materials have poor biocompatibility, uncontrollable degradation, and cannot effectively stop hemostasis and fill bone defects.
The bone hemostatic repair material is used to use bioactive glass and fat-soluble excipients as the main components. By mixing bioactive glass powder and porous particles and excipients, a material that can be shaped can be formed, which can effectively stop bleeding and be in the bone defect area. Gradually absorb and degrade, promoting bone conduction and osteoinduction.
The biocompatibility and degradability of bone hemostasis repair materials are achieved, which can effectively stop hemostatic and gradually repair the bone defect area, avoid hindering the healing of bone wounds, and is low-cost, safe and non-toxic.
Smart Images

Figure CN118161656B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of medical materials, and in particular to a bone hemostatic repair material that can be arbitrarily shaped and a preparation method thereof. Background Art
[0002] Bones are an important part of the human locomotor system and contain a large number of capillaries. Bone injuries, especially large-area bone defects, are often accompanied by capillary bleeding in the bone tissue, which is a common symptom of bone trauma. Bleeding from this type of bone wound is often oozing. If the bleeding is not effectively stopped within a short period of time, the patient's life safety will be difficult to guarantee. The hemostatic methods used clinically (mechanical hemostasis, heat / energy-based hemostasis, chemical hemostasis, and mechanical hemostasis) have also failed to effectively stop bleeding.
[0003] Bioactive glass (BAG) is a silicate glass composed of SiO2, Na2O, CaO and P2O5. The most notable feature of bioactive glass and glass ceramics is that after implantation into the human body, the surface condition changes dynamically over time, and a bioactive hydroxy carbonate apatite (HCA) layer is formed on the surface, providing a bonding interface for the tissue. Most bioactive glasses are Class A bioactive materials, which have both osteoproductive and osteoconductive effects, and have good bonding with bones and soft tissues. BAG is considered to be a good biomaterial that can be used in the field of repair. This kind of restorative material is not only extremely widely used, but also has irreplaceable magical effects in professional products in many fields, such as skin care, whitening and wrinkle removal, burns and scalds, oral ulcers, gastrointestinal ulcers, skin ulcers, fungal killing, bone repair, bonding of soft tissue and bone tissue, etc. It is believed that its appearance will make an outstanding contribution to human health. In addition, BAG has a fast surface reaction; the amorphous two-dimensional structure makes the strength and fracture toughness low; the elastic modulus (30-35MPa) is low, close to that of cortical bone; and the machinable bioglass has good processing properties.
[0004] At present, bone filling materials with bioactive glass as the main component have been widely used in the field of bone defect filling and bone repair. However, bone filling materials are mostly provided in the form of powder or solid molding. Powder is easily dispersed by blood flow, and solid molding is inconvenient to fill bone defects or its size is not compatible. In addition, neither powder bone filling materials nor solid molding bone filling materials can stop bleeding at the bone defect site, and the bone defect site is often accompanied by a lot of bleeding.
[0005] Bone cement made of calcium phosphate and hydroxyapatite as the main materials is used for bone filling or repair. Although it can be shaped arbitrarily, the dense structure of the formed bone cement will hinder bone conductivity and is not conducive to the growth of new bone tissue.
[0006] 202110232431.0 discloses a plastic bone repair material and a preparation method thereof, comprising 35-65 parts of bioactive glass, 15-35 parts of glycerol, 0.5-5 parts of gelatin, and 3-15 parts of polyethylene glycol; excipients made of glycerol, gelatin, and polyethylene glycol. However, in this method, the excipients are all water-soluble materials, which have poor anti-collapse ability, poor mechanical properties, fast material absorption and degradation, and no mesoporous materials are used.
[0007] US9566368B2 discloses a plastic bone graft composition, 40-80% by weight of one or more bioresorbable polymers (polyalkylene oxide polymers: molecular weight 500-1500); about 10-50% by weight of biphasic calcium phosphate particles containing hydroxyapatite and tricalcium phosphate; and about 1-40% by weight of at least one bioactive glass. However, this method mainly uses water-soluble polymers, the material has strong plasticity but poor anti-collapse ability, and no drug loading is used, and no mesoporous materials are used.
[0008] US11338061B2 discloses a dynamic bioactive bone graft material with engineered porosity, the material comprising: a porous matrix comprising a plurality of overlapping and interlocking bioactive glass fibers and bioactive glass particles distributed throughout the fibers. Also included are viscous materials including blood, saline, glycerol, gelatin, plasma or bone marrow. The inorganic phase in the material is mainly in the form of bioactive glass fibers / particles, and a viscous liquid substance is used.
[0009] WO2014 / 152113A2 Bioactive porous composite bone graft implant comprises: a first component comprising bioactive glass; a second component comprising a polymer material; and a third component comprising a bioactive material in particle form. The third component may include bioactive glass, calcium sulfate, calcium phosphate, calcium carbonate, calcium hydroxide or hydroxyapatite. The carrier mentioned in the method is a water-soluble material with poor anti-collapse ability; an additional layer or coating concept of a polymer (biocompatible, bioabsorbable polymer or film-forming agent) is provided on the material in the form of a single fiber or its formed fiber cluster.
[0010] US2023 / 0053789 A1 discloses a bone transplant composition, which contains at least two-phase, three-phase and / or four-phase particles and a carrier. At least one of hydroxyapatite, β-tricalcium phosphate, α-tricalcium phosphate and bioactive glass. The carrier contains additional polyhydroxy compounds (polyols) and their esters, polysaccharides, surfactants and mixtures thereof. In this method, the carrier is a water-soluble material with poor anti-collapse ability; the use of the carrier is disclosed, and the concept of excipients is not mentioned; the bioactive glass in the bone graft is not the main component of the inorganic phase.
[0011] The existing methods cannot meet the actual use requirements of bone hemostatic repair materials and have certain shortcomings. Therefore, the development of a new type of bone hemostatic repair material that can be arbitrarily shaped is of great significance for the medical use of bone defect filling. Summary of the invention
[0012] The technical problem to be solved by the present invention is that the existing bone hemostatic repair materials have poor biocompatibility and uncontrollable degradation. The present invention provides a bone hemostatic repair material that can be arbitrarily shaped and a preparation method thereof.
[0013] In order to solve the above technical problems, in a first aspect, the present invention provides a bone hemostatic repair material that can be arbitrarily shaped. The raw materials for preparing the bone hemostatic repair material include 4 to 80 parts of bioactive glass and 1 to 50 parts of excipients by weight.
[0014] The bone hemostatic repair material provided by the invention has good biocompatibility and degradability, and has a wide range of raw materials, low cost, and is safe and non-toxic.
[0015] The bone hemostatic repair material provided by the present invention can be shaped and applied to fill the cavity of the bleeding bone wound surface when used to achieve the purpose of effective hemostasis. It can also be shaped and filled arbitrarily according to the size of the bone defect. In the process of bone repair, it is gradually absorbed and degraded, and plays a role in bone conduction and bone induction in the process of gradual repair of the bone defect site without hindering the healing of the bone wound surface.
[0016] The more the bioactive glass powder and porous particles with larger particle sizes are contained in the bone hemostatic repair material, and the lower the proportion of excipients, the harder the bone hemostatic repair material becomes, and the spreadability, dispersibility and anti-collapse properties become worse. Conversely, the more excipients are contained and the less bioactive glass is contained, the worse the blocking ability will be.
[0017] The bioactive glass of the present invention is 4 to 80 parts, for example, 4 parts, 10 parts, 20 parts, 30 parts, 40 parts, 50 parts, 60 parts, 70 parts or 80 parts.
[0018] Preferably, the bioactive glass comprises any one of silicate bioactive glass, phosphate bioactive glass or borate bioactive glass, or a combination of at least two thereof.
[0019] The models of silicate bioactive glass can be the following: A / W glass-ceramics, Ceravital (new bioactive glass-ceramics), Bioverit (cuttable bioactive glass crystals), S53P4, 45SBG, 13-93, 58SBG, 68SBG, 77SBG and 86SBG, and the models of borate bioactive glass can be 6P53B, 13-93B1, 13-93B2 and 13-93B3, etc., for example, it can be 45SBG, 58SBG or a combination of 45SBG and 58SBG.
[0020] Preferably, the bioactive glass is in the form of a mixture of powdered bioactive glass and porous granular bioactive glass, and the mass ratio of the powdered bioactive glass to the porous granular bioactive glass is 1:1-100.
[0021] In the present invention, the bioactive glass can be prepared by blending bioactive glass powder and porous bioactive glass. The bioactive glass powder has strong activity and can induce the formation of bone-like hydroxyapatite, which is helpful for bone regeneration.
[0022] Preferably, the particle size of the powdered bioactive glass is in the range of 0.001 to 100 μm, for example, it can be 0.001 μm, 1 μm, 5 μm, 10 μm, 20 μm, 30 μm, 40 μm, 50 μm, 60 μm, 70 μm, 80 μm, 90 μm or 100 μm.
[0023] The porous granular bioactive glass has a particle size range of 1 to 2000 μm and a pore size of 100 to 1000 μm.
[0024] Preferably, the porous granular bioactive glass comprises large-particle porous granular bioactive glass and mesoporous porous granular bioactive glass, which are mixed in any proportion.
[0025] The large particles in the porous bioactive glass have a three-dimensional interconnected macroporous structure, which can enhance bone conductivity and facilitate the growth of new bone tissue; the mesoporous bioactivity in the porous bioactive glass can have better drug loading and sustained release properties.
[0026] Preferably, the particle size of the large-particle porous granular bioactive glass is in the range of 100 to 2000 μm; for example, it may be 100 μm, 200 μm, 500 μm, 800 μm, 1000 μm, 2000 μm, etc.
[0027] Preferably, the mesoporous porous granular bioactive glass has a particle size range of 1 to 100 μm, for example, it can be 1 μm, 5 μm, 10 μm, 20 μm, 40 μm, 80 μm or 100 μm, etc., and the pore size is 1 to 500 nm, for example, it can be 10 nm, 20 nm, 30 nm, 40 nm, 50 nm, 100 nm, 200 nm, 400 nm or 500 nm, etc.
[0028] The particle size of the powder is very fine. When the bone hemostatic repair material comes into contact with a bleeding wound, it can effectively absorb the exuded blood and adhere to the wound to play a hemostatic role.
[0029] The excipient of the present invention is 1 to 50 parts, for example, 10 parts, 20 parts, 30 parts, 40 parts or 50 parts, etc. The excipients are all fat-soluble materials, which can provide an arbitrary shaping carrier for the implant while maintaining the good anti-blood collapse ability of the implant.
[0030] Preferably, the excipient comprises any one of polyester, animal oil, vegetable oil, fatty acid or vitamin, or a combination of at least two thereof.
[0031] Preferably, the bone hemostatic repair material further comprises 0.1 to 10 parts of a porogen, for example, 0.1 parts, 1 parts, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 8 parts or 10 parts.
[0032] The porogen includes any one of polyol, mannitol, starch, cellulose or cellulose salt, or a combination of at least two thereof.
[0033] It also contains a certain proportion of porogens, which are water-soluble materials. When encountering blood or tissue fluid, they will be dissolved and absorbed in advance. The repair material will form a gradient degradation and absorption, and the material will form a porous structure, further promoting bone conductivity.
[0034] Preferably, the bone hemostatic repair material further includes 0.1 to 25 parts of a bone repair additive, for example, 0.1 parts, 2 parts, 5 parts, 10 parts, 15 parts, 20 parts or 25 parts.
[0035] The bone repair additive includes any one or at least two components of calcium phosphate, calcium sulfate, hydroxyapatite, autologous demineralized bone matrix, allogeneic demineralized bone matrix, bone collagen, bone growth factor, angiogenesis promoting factor or antibacterial material.
[0036] In a second aspect, the present invention provides a method for preparing the bone hemostatic repair material as described above, the preparation method comprising the following steps:
[0037] (1) mixing and stirring the bioactive glass, the excipient, and optionally the porogen and the bone repair additive to obtain a mixture;
[0038] (2) injecting the mixture obtained in step (1) into a mold, cooling and demoulding to obtain the bone hemostatic repair material.
[0039] Preferably, the mixing and stirring temperature in step (1) is 50 to 150°C.
[0040] The preparation method of the present invention, which comprises mixing and stirring at 50-150° C., injecting into a mold, and cooling to room temperature, can better control the uniformity of the material, has a simple process, low cost, and is easy to realize industrial production.
[0041] The implementation of the present invention has the following beneficial effects:
[0042] The bone hemostatic repair material provided by the present invention combines the advantages of plasticizers and bioactive glass. The material is non-irritating to the human body, has no obvious toxicity, is rich in raw materials, has low production costs, has good biocompatibility, and avoids the toxic residues caused by the introduction of chemical cross-linking agents. The material is convenient to use clinically, can be shaped, and can be applied and filled into the cavity of the bleeding bone wound surface to achieve the purpose of effective hemostasis. It can also be arbitrarily shaped and filled according to the size of the bone defect. In the process of bone repair, it is gradually absorbed and degraded, and plays a role in bone conduction and bone induction in the process of gradually repairing the bone defect site, and does not hinder the healing of the bone wound surface. It is a bone hemostatic repair material that can be widely used in bone defect filling and can be arbitrarily shaped. BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1 This is a graph showing the results of the bone hemostatic repair material blocking experiment provided in Example 1.
[0044] Figure 2 This is a comparison chart of the experimental results of the smearable bone hemostatic repair material provided in Example 1.
[0045] Figure 3 This is a sternal clearance diagram of the CT examination result after the bone hemostatic repair material provided in Example 1 was implanted into the sternum.
[0046] Figure 4 This is a diagram of the mechanical properties of the sternum obtained from a CT scan after the bone hemostatic repair material provided in Example 1 was implanted into the sternum.
[0047] Figure 5 This is a diagram showing the growth of new bone after the bone hemostatic repair material provided in Example 1 is implanted into the sternum.
[0048] Figure 6 This is a diagram of new bone growth after the control sample material was implanted into the sternum.
[0049] Figure 7 This is a degradation curve diagram of the bone hemostatic repair material provided in Example 2-5 when immersed in Tris-HCl. DETAILED DESCRIPTION
[0050] The specific embodiments of the present invention are described in detail below. It should be understood that the specific embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0051] The endpoints and any values of the ranges disclosed in this article are not limited to the precise ranges or values, and these ranges or values should be understood to include values close to these ranges or values. For numerical ranges, the endpoint values of each range, the endpoint values of each range and the individual point values, and the individual point values can be combined with each other to obtain one or more new numerical ranges, which should be considered as specifically disclosed in this article.
[0052] Example 1
[0053] This embodiment provides a bone hemostasis repair material
[0054] (1) Add 70 parts of 45S5 bioactive glass (prepared by high temperature melting method, powdered, with a particle size of less than 30 μm) and 20 parts of tocopherol acetate (excipient) into a blender and stir at 80° C. until the mixture is uniform.
[0055] (2) Add 10 parts of porous β-tricalcium phosphate (additive) to the mixture of step 1, and continue to stir and mix evenly; stop heating, and continue stirring until the mixture reaches room temperature, thereby preparing a bone hemostatic repair material that can be arbitrarily shaped, and sterilize the mixture by electron beam irradiation, with a sterilization dose of 25 KGy.
[0056] In order to evaluate the hemostatic performance of the arbitrarily shaped bone hemostatic repair material prepared in Example 1, an in vitro packing and clogging experiment and a smearing experiment were carried out.
[0057] The packing and plugging experimental model uses a PVC tube with a diameter of 4mm / 6mm / 8mm. One end is sealed with a bone hemostatic repair material that can be arbitrarily molded (the edge is sanded to simulate the bone wound environment), and the other end is connected to a pressure leak detector with a test pressure of 20kPa. 37℃ saline is injected and observed for 10 minutes to see if there is leakage.
[0058] Blocking test pictures Figure 1 The experimental results are shown in Table 1, which proves that the bone hemostatic repair material with arbitrary shape prepared in this case has a good blocking (hemostatic) effect, indicating that the material can solve the hemostasis problem of bleeding on cancellous bone wounds in orthopedic surgery and craniotomy.
[0059] The smearable experiment simulates the bleeding cancellous bone wound in vitro. After the arbitrarily shaped bone hemostatic repair material is smeared, it can be evenly attached to the bleeding wound surface to achieve the purpose of hemostasis. In the experiment, the arbitrarily shaped bone hemostatic repair material is kneaded by hand for 3 minutes to improve the plasticity, and then the arbitrarily shaped bone hemostatic repair material is smeared on a clean glass culture dish to obtain the corresponding stripe smear marks, and compared with commercial plastic bone wax. The experimental pictures are as follows Figure 2 As shown, A is the streak trace of the arbitrarily shaped bone hemostatic repair material, and B is the streak trace of the commercial plastic bone wax. It can be seen that the arbitrarily shaped bone hemostatic repair material forms relatively clean and smooth streaks, has good spreadability, and is comparable to commercial bone wax.
[0060] Table 1
[0061] Plugging Experimental Model Blocking results 4mm diameter PVC pipe good 6mm diameter PVC pipe good 8mm diameter PVC pipe good
[0062] Further animal testing to verify the effectiveness of bone repair materials
[0063] The animal experiment used a porcine sternotomy trauma model. An 8-cm incision was made on the midline of the chest to fully expose the three lower segments of the sternum. The periosteum in the surgical area was peeled off, and the three lower segments of the sternum were cut open to completely expose the sternal cross section. Bone repair materials and control samples were filled into the sternal cross section to observe the growth of new bone.
[0064] CT examination of sternal clearance at different implantation stages, as follows Figure 3 and Figure 4 .
[0065] The sternal gap of the bone hemostatic repair material provided in Example 1 is significantly smaller than that of the control group at different periods, indicating that the bone repair material of the present invention is used to fill the sternal defect, and the new bone grows faster. Figure 4 It can be seen that the bone hemostatic repair material provided in Example 1 has better mechanical properties, indicating that its overall performance is better.
[0066] The new bone growth at the implantation site 8 weeks after implantation Figure 5 and Figure 6 As shown. Figure 5 The experimental group of Example 1, Figure 6 After 8 weeks, the bone hemostatic repair material of the present invention which can be arbitrarily shaped has completely repaired the sternum wound surface, while the control group still has a large area of bone defect.
[0067] Embodiment 2-5
[0068] The preparation methods of the arbitrarily shaped bone hemostatic repair materials provided in Examples 2, 3, 4 and 5 are basically the same, except that the proportions of the components are inconsistent, as shown in Table 2 below.
[0069] Table 2
[0070]
[0071] (1) Add 45S5 bioactive glass and castor oil into a blender according to the formula, and stir at 80°C until the mixture is uniform.
[0072] (2) Add porous β-tricalcium phosphate to the mixture of step (1), and continue to stir and mix evenly. Stop heating, continue to stir, add polyethylene glycol when the temperature drops to 50°C, and continue to stir evenly until the temperature reaches room temperature, so as to prepare a bone hemostatic repair material that can be shaped arbitrarily. The samples of the prepared bone hemostatic repair material with different contents of porogens are coded as Y0, Y2.5, Y5, and Y10, respectively, and the samples are sterilized by electron beam irradiation, and the irradiation sterilization dose is 25KGy.
[0073] In order to determine the effect of different porogen contents on the degradation rate of arbitrarily shaped bone hemostatic repair materials, Tris-HCl buffer solution was used for in vitro immersion. Y / V Tris-HCl =200mL / g, and the initial mass m0 of the material was recorded before immersion. Four parallel samples were prepared for each method, and the Tris-HCl buffer solution was replaced at different times (0h, 12h, 24h, 72h, 120h, 168h (1W), 2W, 4W and 8W). Before replacing the buffer solution at each time point, the sample was carefully filtered and dried, and the remaining mass m was recorded. t , and then replace with new Tris-HCl buffer solution to obtain data.
[0074] According to the remaining mass / % = (m t / m0)*100% to calculate the residual mass, and thus the degradation curve of the bone hemostatic repair material with different contents of porogens can be arbitrarily shaped. Figure 7 As shown. According to the explanation curve, with the increase of porogen, the degradation rate of the arbitrarily shaped bone hemostatic repair material becomes faster. For example, the remaining rate of Y0 in 4 weeks is 27.75%, the remaining rate of Y5 in 4 weeks is 15.96%, and the remaining rate of Y10 in 4 weeks is 10.36%. It can be seen that by changing the content of porogen, the degradation rate of the arbitrarily shaped bone hemostatic repair material can be controlled, and the gradient degradation of the material can be achieved, which is convenient and feasible in practical application.
[0075] Example 6
[0076] This embodiment provides a bone hemostatic repair material that can be arbitrarily shaped
[0077] (1) Add 40 parts of 45S bioactive glass (prepared by high temperature melting method, powder, particle size range is less than 30 μm), 20 parts of 45S bioactive glass (prepared by high temperature melting method, porous granules, particle size range is 110-1000 μm, pore size range is 100-200 μm) and 30 parts of polyethylene glycol 1000 into a blender and stir at 100°C until the mixture is uniform.
[0078] (2) Add 8 parts of porous β-tricalcium phosphate and 2 parts of calcium sulfate to the mixture of step 1, and continue to stir and mix evenly; stop heating, and continue stirring until the mixture reaches room temperature, thereby preparing a bone hemostatic repair material that can be shaped arbitrarily. Inject the mixture into a mold. Cool to room temperature, and demold to obtain a bone hemostatic repair material that can be shaped arbitrarily. The prepared bone hemostatic repair material is further sterilized by electron beam irradiation, with an irradiation sterilization dose of 25 KGy.
[0079] Comparative Example 1
[0080] This comparative example is substantially the same as Example 1, except that the bioactive glass is replaced with calcium phosphate powder.
[0081] The bone hemostatic repair material prepared with calcium phosphate powder as raw material can be arbitrarily shaped and has good blocking ability, but its in vitro degradation rate is not as fast as the arbitrarily shaped bone hemostatic repair material in Example 1. Moreover, calcium phosphate has bone conduction ability but not bone induction ability, while bioactive glass has both bone conduction ability and bone induction ability, can bond with hard and soft tissues at the same time, and has better biological activity.
[0082] Therefore, this comparative example is inferior to the arbitrarily shaped bone hemostatic repair material of Example 1 in terms of bone repair.
[0083] Comparative Example 2
[0084] This comparative example is substantially the same as Example 1, except that this comparative example does not contain an excipient.
[0085] Powdered bioactive glass is mixed with porous β-tricalcium phosphate to obtain a powdered bone hemostatic repair material. Although the powdered bone hemostatic repair material has biological activity and the ability to induce bone repair, it cannot be arbitrarily shaped during use, has poor blocking ability, and has poor anti-collapse ability in simulated body fluids.
[0086] Therefore, the bone hemostatic repair material without excipients is inferior to the arbitrarily shaped bone hemostatic repair material in Example 1 in terms of blocking performance and anti-collapse performance.
[0087] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A bone hemostatic repair material that can be shaped arbitrarily. It is characterized in that The raw materials for preparing the bone hemostatic repair material include 4 to 80 parts of bioactive glass and 10 to 50 parts of excipients by weight; the composition of the bioactive glass is a mixture of powdered bioactive glass and porous granular bioactive glass, and the mass ratio of the powdered bioactive glass to the porous granular bioactive glass is 1:1 to 100; the particle size range of the powdered bioactive glass is 0.001 to 100 μm; the particle size range of the porous granular bioactive glass is 1 to 2000 μm, and the pore size is 100 to 1000 μm; the porous granular bioactive glass includes large-particle porous granular bioactive glass and mesoporous porous granular bioactive glass, and the two are mixed in any proportion; Among them, the particle size of large-particle porous granular bioactive glass ranges from 100 to 2000 μm; the particle size of mesoporous porous granular bioactive glass ranges from 1 to 100 μm and the pore size is 1 to 500 nm; The excipient is a fat-soluble material, and the excipient includes any one of polyester, animal oil, vegetable oil, fatty acid or vitamin, or a combination of at least two of them.
2. The bone hemostatic repair material according to claim 1, It is characterized in that The bioactive glass includes any one of silicate bioactive glass, phosphate bioactive glass or borate bioactive glass, or a combination of at least two of them.
3. The bone hemostatic repair material according to claim 1, It is characterized in that The bone hemostatic repair material also includes 0.1 to 10 parts of a porogen; The porogen includes any one of polyol, mannitol, starch, cellulose or cellulose salt, or a combination of at least two thereof.
4. The bone hemostatic repair material according to claim 1, It is characterized in that The bone hemostatic repair material also includes 0.1 to 25 parts of a bone repair additive; The bone repair additive includes any one or at least two components of calcium phosphate, calcium sulfate, hydroxyapatite, autologous demineralized bone matrix, allogeneic demineralized bone matrix, bone collagen, bone growth factor, angiogenesis promoting factor or antibacterial material.
5. The method for preparing the bone hemostatic repair material according to any one of claims 1 to 4, It is characterized in that The preparation method comprises the following steps: (1) mixing and stirring the bioactive glass, an excipient, and optionally a porogen and a bone repair additive to obtain a mixture; (2) Injecting the mixture obtained in step (1) into a mold, cooling and demoulding to obtain the bone hemostatic repair material.
6. The preparation method according to claim 5, It is characterized in that The mixing and stirring temperature in step (1) is 50-150°C.
Citation Information
Patent Citations
Dynamic bioactive bone graft material having an engineered porosity
US11338061B2
Bone graft composition
US20230053789A1
Moldable bone graft compositions
US9566368B2
Bioactive porous composite bone graft implants
WO2014152113A2
Bone repairing material and preparation method thereof
CN102488927A
